Adult High-Grade (Diffuse) Glioma

作者: Katharine McNeill , Kenneth Aldape , Howard A. Fine

DOI: 10.1007/978-1-4939-1830-0_6

关键词:

摘要: Malignant gliomas are the most common malignant brain tumors in adults. Although outcomes have improved over past decade with advent of new therapies, they remain aggressive and usually incurable. Our understanding genetic molecular changes that drive these has grown exponentially due to data gathered by Cancer Genome Atlas other groups, this is already being translated into therapeutic strategies. As we move further era personalized medicine, an will be more critical than ever developing individualized treatment In chapter, review our current biology tumors, as well treatments used or under investigation target particular biologic processes.

参考文章(168)
McLendon Re, Bigner Dd, Fuchs He, Friedman Ah, Rasheed Bk, Bigner Sh, Friedman Hs, Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene. ,vol. 10, pp. 2243- 2246 ,(1995)
Benjamin E. Alderete, C. David James, Robert B. Jenkins, Wanguo Liu, Lori Frederick, PTEN/MMAC1 Mutations and EGFR Amplification in Glioblastomas Cancer Research. ,vol. 57, pp. 5254- 5257 ,(1997)
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
Oliver Bögler, H. J Su Huang, Webster K. Cavenee, Loss of Wild-Type p53 Bestows a Growth Advantage on Primary Cortical Astrocytes and Facilitates Their in Vitro Transformation Cancer Research. ,vol. 55, pp. 2746- 2751 ,(1995)
Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Kurt A. Jaeckle, Athanassios P. Kyritsis, Michael D. Prados, Victor A. Levin, W.K. Alfred Yung, Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Journal of Clinical Oncology. ,vol. 17, pp. 2572- 2578 ,(1999) , 10.1200/JCO.1999.17.8.2572
Nader Sanai, Mei-Yin Polley, Michael W. McDermott, Andrew T. Parsa, Mitchel S. Berger, An extent of resection threshold for newly diagnosed glioblastomas. Journal of Neurosurgery. ,vol. 115, pp. 3- 8 ,(2011) , 10.3171/2011.2.JNS10998
Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, Sergio Rosemberg, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. Lopez, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Diaz, Hai Yan, Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. ,vol. 3, pp. 709- 722 ,(2012) , 10.18632/ONCOTARGET.588
D Scheie, M Cvancarova, S Mørk, K Skullerud, PA Andresen, I Benestad, E Helseth, T Meling, K Beiske, None, Can morphology predict 1p/19q loss in oligodendroglial tumours? Histopathology. ,vol. 53, pp. 578- 587 ,(2008) , 10.1111/J.1365-2559.2008.03160.X
S. Zhao, Y. Lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, Y. Peng, J. Ding, Q. Lei, K.-L. Guan, Y. Xiong, Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α Science. ,vol. 324, pp. 261- 265 ,(2009) , 10.1126/SCIENCE.1170944